Stories
US Grants Tariff Relief to India, 19 Nations on Speciality Drugs
M
Moneycontrol•28-09-2026, 22:45
US Grants Tariff Relief to India, 19 Nations on Speciality Drugs
- •The US will not impose ad valorem tariffs on certain speciality drugs and associated ingredients imported from India and 19 other countries.
- •These drugs are used to treat rare medical conditions, infertility, and include cell and gene therapies, ADCs, and animal pharmaceuticals.
- •The zero per cent tariff applies to countries with existing or forthcoming trade and security framework agreements with the US.
- •This relief is part of the implementation of President Trump's April proclamation adjusting pharmaceutical imports under Section 232 of the Trade Expansion Act.
- •Generic pharmaceutical products and their associated ingredients are not subject to the Section 232 pharmaceutical tariffs.
Key Questions Answered
India and 19 other countries, including Argentina, Bangladesh, Britain, Switzerland, South Korea, and Vietnam, received zero tariff rates on certain speciality drugs and associated ingredients.
Eligible products include drugs for rare diseases, infertility treatments, cell therapies, gene therapies, antibody-drug conjugates, animal pharmaceuticals, and their components.
Qualifying products from these jurisdictions received a zero per cent tariff because they maintain a current or forthcoming trade and security framework agreement with the US.
